Cardiology, Internal Medicine, Family Medicine

Valvular Heart Disease - Top 10 Points for your practice

R. A. Nishimura, M.D.

ACC/AHA Valve Guidelines: Top 10 Points for your Practice
R. A. Nishimura, M.D., MACC, MACP, Mayo Clinic

View transcript
Share via Email

Jump to...

  • 0:16

    Case 1: 64 YO male; asymptomatic, severe AS; normal EF

  • 3:09

    Case 2: 72 YO male; prior St J AVR; scheduled prostatectomy; taking wafarin; INR 2.7; asymptomatic; EF 59%

  • 7:01

    Natural History of Aortic Stenosis - Infographic

  • 8:35

    New 2014 Guidelines

  • 11:42

    ACC/AHA Heart Failure Guidelines

  • 12:58

    ACC/AHA Valve Disease Guidelines - Stages A-D

  • 14:50

    Point 1: Definition of severe asymptomatic aortic stenosis

  • 15:33

    Point 2: Recommendations for progressive aortic stenosis disease

  • 16:38

    C1 & C2 stages of severe asymptomatic aortic stenosis

  • 18:02

    Case 1: 64 YO retired business man

  • 18:35

    Point 3: Understand the difference between stage C1 and C2

  • 19:46

    Summary of Valve Disease Stages A-D

  • 20:07

    Long Term Followup of Asymptomatic Severe Aortic Stenosis

  • 21:25

    Point 4: Operative Risk for Aortic Valve Replacement

  • 24:26

    Point 5: The Importance of Shared Decision-Making

  • 29:21

    Point 6: Late manifestation of symptoms - severe aortic stenosis

  • 30:10

    Frailty Evaluation

  • 30:15

    TAVR Breakthrough

  • 32:22

    STS Risk Calculator

  • 33:36

    Aortic Stenosis in the Elderly - Infographic

  • 34:52

    Point 7: Elderly Patients with Valve Disease

  • 37:01

    Point 8: Management of Coagulation

  • 39:01

    Point 9: Management of Coagulation - Bridging

  • 41:59

    Point 10: Infective Endocarditis Prophylaxis